AN69ST membranes adsorb nafamostat mesylate and affect the management of anticoagulant therapy: a retrospective study

BACKGROUND: In Japan, nafamostat mesylate (NM) is frequently used as an anticoagulant during continuous renal replacement therapy (CRRT). The dialyzer membrane AN69ST has been reported to adsorb NM and affect the management of anticoagulant therapy. However, the adsorbed amount has not yet been quan...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Intensive Care
Hlavní autoři: Hirayama, Takahiro, Nosaka, Nobuyuki, Okawa, Yasumasa, Ushio, Soichiro, Kitamura, Yoshihisa, Sendo, Toshiaki, Ugawa, Toyomu, Nakao, Atsunori
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5516335/
https://ncbi.nlm.nih.gov/pubmed/28729905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40560-017-0244-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky